In response to a recent article in The New York Times Magazine, “Our Feel Good War on Breast Cancer,” Dr. Lora Weiselberg, a leading expert in breast cancer from Hofstra North Shore-LIJ School of Medicine, sets the record straight.
James Alterbaum’s extensive background in law and business make him a valuable asset to the Foundation’s Board of Directors.
Come visit the Maurer Foundation booth Thursday, May 23rd, at Long Island’s largest business-to-business event, the Hauppauge Industrial Association-Long Island (HIA-LI) Annual Trade Show and Conference.
Definition, treatment, survival rates, prognosis and statistics of triple negative breast cancer.
The researchers found that women with implants had a 26% higher risk of being diagnosed at a later stage of breast cancer than those without, coupled with a 38% higher risk of death from breast cancer than those women without implants.
New research suggests some breast cancer cell growth might be significantly reduced—and possibly prevented in the first place—by consistent low doses of aspirin.